Pfizer Inc. (BMV:PFE)
463.96
-6.36 (-1.35%)
At close: Oct 9, 2025
Pfizer Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2011 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2011 - 2019 |
Cash & Equivalents | 1,638 | 1,043 | 2,853 | 416 | 1,944 | 1,786 | Upgrade |
Short-Term Investments | 11,611 | 19,434 | 9,837 | 22,316 | 29,125 | 10,437 | Upgrade |
Cash & Short-Term Investments | 13,249 | 20,477 | 12,690 | 22,732 | 31,069 | 12,223 | Upgrade |
Cash Growth | 86.61% | 61.36% | -44.18% | -26.83% | 154.19% | 26.72% | Upgrade |
Accounts Receivable | 12,078 | 11,463 | 11,566 | 10,952 | 11,479 | 7,913 | Upgrade |
Inventory | 11,669 | 10,851 | 10,189 | 8,981 | 9,059 | 8,020 | Upgrade |
Other Current Assets | 6,706 | 7,567 | 8,889 | 8,594 | 8,086 | 6,910 | Upgrade |
Total Current Assets | 43,703 | 50,358 | 43,333 | 51,259 | 59,693 | 35,067 | Upgrade |
Net Property, Plant & Equipment | 18,776 | 18,393 | 18,940 | 16,274 | 14,882 | 13,745 | Upgrade |
Other Intangible Assets | 52,702 | 55,411 | 64,900 | 43,370 | 25,146 | 28,337 | Upgrade |
Goodwill | 68,997 | 68,527 | 67,783 | 51,375 | 49,208 | 49,556 | Upgrade |
Long-Term Investments | 2,120 | 2,227 | 15,368 | 15,069 | 21,526 | 20,262 | Upgrade |
Other Long-Term Assets | 19,798 | 18,479 | 16,177 | 19,856 | 11,020 | 7,262 | Upgrade |
Total Assets | 206,095 | 213,396 | 226,501 | 197,205 | 181,476 | 154,229 | Upgrade |
Accounts Payable | 5,166 | 5,633 | 6,710 | 6,809 | 5,578 | 4,283 | Upgrade |
Accrued Expenses | 2,447 | 3,838 | 2,776 | 3,407 | 3,332 | 3,049 | Upgrade |
Short-Term Debt | 4,295 | 6,946 | 10,350 | 2,945 | 2,241 | 2,703 | Upgrade |
Unearned Revenue | 1,123 | 1,511 | 2,700 | 2,520 | 3,067 | 1,113 | Upgrade |
Other Current Liabilities | 24,695 | 25,067 | 25,258 | 26,458 | 28,454 | 14,772 | Upgrade |
Total Current Liabilities | 37,726 | 42,995 | 47,794 | 42,138 | 42,671 | 25,920 | Upgrade |
Long-Term Debt | 57,502 | 57,405 | 61,538 | 32,884 | 36,195 | 37,133 | Upgrade |
Other Long-Term Liabilities | 21,855 | 24,499 | 27,880 | 26,265 | 25,147 | 27,703 | Upgrade |
Total Long-Term Liabilities | 79,357 | 81,904 | 89,418 | 59,149 | 61,342 | 64,836 | Upgrade |
Total Liabilities | 117,083 | 124,899 | 137,213 | 101,288 | 104,013 | 90,756 | Upgrade |
Common Stock | 481 | 480 | 478 | 476 | 473 | 470 | Upgrade |
Treasury Stock | -115,010 | -114,763 | -114,487 | -113,969 | -111,361 | -110,988 | Upgrade |
Additional Paid-in Capital | 94,053 | 93,603 | 92,631 | 91,802 | 90,591 | 88,674 | Upgrade |
Accumulated Other Comprehensive Income | -8,438 | -7,842 | -7,961 | -8,304 | -5,897 | -5,310 | Upgrade |
Retained Earnings | 117,609 | 116,725 | 118,353 | 125,656 | 103,394 | 90,392 | Upgrade |
Total Common Shareholders' Equity | 88,695 | 88,203 | 89,014 | 95,661 | 77,201 | 63,238 | Upgrade |
Minority Interest | 317 | 294 | 274 | 256 | 262 | 235 | Upgrade |
Shareholders' Equity | 89,012 | 88,497 | 89,288 | 95,916 | 77,462 | 63,473 | Upgrade |
Total Liabilities & Equity | 206,095 | 213,396 | 226,501 | 197,205 | 181,476 | 154,229 | Upgrade |
Total Debt | 61,797 | 64,351 | 71,888 | 35,829 | 38,436 | 39,836 | Upgrade |
Net Cash (Debt) | -48,548 | -43,874 | -59,198 | -13,097 | -7,367 | -27,613 | Upgrade |
Net Cash Per Share | -8.51 | -7.70 | -10.37 | -2.28 | -1.29 | -4.90 | Upgrade |
Book Value | 88,695 | 88,203 | 89,014 | 95,661 | 77,201 | 63,238 | Upgrade |
Book Value Per Share | 15.54 | 15.47 | 15.59 | 16.69 | 13.53 | 11.23 | Upgrade |
Tangible Book Value | -33,004 | -35,735 | -43,669 | 916 | 2,847 | -14,655 | Upgrade |
Tangible Book Value Per Share | -5.78 | -6.27 | -7.65 | 0.16 | 0.50 | -2.60 | Upgrade |
Updated Jun 29, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.